140 results
8-K
EX-99.1
l5jv77746b
25 Mar 24
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
ykq5 jepormobrfei7
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
424B7
5kfmqtn5magrmr8k
15 Mar 24
Prospectus with selling stockholder info
3:53pm
8-K/A
EX-99.1
or2avuny 96sqpge
6 Mar 24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
4:07pm
8-K
EX-99.1
n1i2d5pvxm rlmipn8
29 Feb 24
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
4:04pm
8-K
EX-4.1
wumd35csz9soui6s
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
8-K
EX-99.1
lt797b
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
8-K
EX-99.1
cz5cvad uk2fjzni
6 Nov 23
Fennec Pharmaceuticals Announces Third Quarter 2023
7:38pm
8-K/A
EX-10.1
007ayn98wrx
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K/A
EX-99.1
qzyedvow03boz
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am